SQUAWK/NEWS
Account
Account
Menu
Live News EQUITY FLASH M impact

VRXA Expands R&D Hub

VERAXA Biotech expands its R&D hub in Heidelberg, increasing laboratory space by over 60% to accelerate clinical development of its BiTAC-TCE and ADC programs

VRXA

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.